AI assistant
Sending…
RAPT Therapeutics, Inc. — Director's Dealing 2021
Jan 5, 2021
32942_dirs_2021-01-04_258ed88a-dc30-41c5-a0d6-a1f418e6bab5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RAPT Therapeutics, Inc. (RAPT)
CIK: 0001673772
Period of Report: 2021-01-04
Reporting Person: HO WILLIAM (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-04 | Common Stock | S | 225 | $19.75 | Disposed | 69189 | Direct |
| 2021-01-04 | Common Stock | S | 775 | $19.75 | Disposed | 68414 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.
More from RAPT Therapeutics, Inc.
Regulatory Filings
2026
Mar 18
M&A Activity
2026
Mar 3
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 9
Merger & Acquisition
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2